Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 43598-510

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 43598-510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Chemical structure of Esomeprazole Magnesium showing two esomeprazole molecules with magnesium ion (Mg2+) complexed, including three water molecules (3 H2O). The structure depicts aromatic rings, methoxy groups, and a sulfoxide moiety in the molecule.*

FDA Label Image

Figure2 (Figure2)

A line graph depicting percent maintained over a 6-month period for different Esomeprazole magnesium dosages (40 mg, 20 mg, 10 mg) and placebo groups. The x-axis represents months, while the y-axis shows the percentage maintained, illustrating comparative maintenance rates across dosages and placebo.*

FDA Label Image

Figure3 (Figure3)

A line graph depicting the percent of maximum maintained over six months for Esomeprazole 40 mg, 20 mg, 10 mg, and placebo groups. The y-axis represents percent maintained, and the x-axis shows months from 1 to 6. Multiple lines compare the performance of different Esomeprazole strengths and placebo.*

FDA Label Image

Figure4 (Figure4)

A line graph depicting the percent of patients symptom-free over 28 diary days for Esomeprazole Magnesium 40 mg, 20 mg, and placebo groups. The y-axis represents the percent symptom-free ranging from 0 to 100, and the x-axis represents diary days from 0 to 28. Three trend lines compare symptom-free rates for the three groups over time.*

FDA Label Image

Figure5 (Figure5)

A line graph showing the percent of patients symptom-free over a 28-day diary period for Esomeprazole Magnesium 20 mg, 40 mg, and placebo groups. The x-axis represents diary days from 0 to 28, and the y-axis represents the percent of patients symptom-free from 0% to 100%. Separate lines illustrate dosing groups and placebo outcomes over time.*

FDA Label Image

Container1 (Container1)

Label for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg by Dr. Reddy's Laboratories Inc. The label includes NDC 43598-509-90, container size of 90 capsules, and states Rx only. Additional information includes storage instructions, dosing, and a QR code for the medication guide.*

FDA Label Image

Container2 (Container2)

Esomeprazole Magnesium Delayed-Release Capsules USP, 40 mg, packaged in a bottle containing 90 capsules. The label includes usage instructions, NDC 43598-510-90, and is labeled by Dr. Reddy's Laboratories Inc. The design features blue and orange text on a white background, with a barcode and a QR code linking to the medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.